This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Innovative Vaccine Approaches - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Mariagrazia Pizza, Galit Alter and Gordon Dougan
Date: June 28 - 30, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Sponsored by AstraZeneca, Biolegend, Merck & Co., Inc., and Moderna
For important information on the coronavirus, please click here
Summary of Meeting:
Vaccines have the power to prevent and potentially eradicate a wide range of infectious diseases, representing one of the most effective life-saving measures at our disposal against global health threats. The recent coronavirus pandemic has brought the importance and urgency of vaccine development efforts into sharp focus. Moreover, the vaccinology field is evolving very rapidly, thanks to advances in our understanding of microbiology, immunology and genomics, as well as advances in structural analysis of antigens and antigen-antibody complexes and impacts of variation. Over the years, this field has also experienced an elucidation of mechanisms of immunity and protection, and identification of correlates. However, many questions are still unsolved and innovative approaches are needed to address new vaccine challenges like antimicrobial resistance, emerging infectious diseases, cancer and diseases associated with our aging population. This conference will cover the latest advances and novel approaches towards vaccine development, including: (1) novel antigen delivery systems; (2) in vitro and in vivo model systems for vaccine appraisal (3) the use of human challenge models; (4) the role of ‘systems biology’ in the comprehensive analysis of immune correlates, biomarker identification and safety; (5) machine-learning approaches to define correlations between antibody repertoires and protection; and (6) strategies for developing low cost vaccines for economically challenged populations. Together these topics will provide attendees with the new ideas and tools to continue to forge new frontiers in vaccine capabilities.
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AstraZenecaBioLegend, Inc.Merck & Co., Inc.Moderna
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI161938-01
Funding for this conference was made possible (in part) by 1R13AI161938-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found